KVAC Faces Nasdaq Delisting; Trading Suspension Begins August 3
KVAC sits 16% above its 52-week low of $10.67.
Summary
Keen Vision Acquisition Corp. faces Nasdaq delisting after missing the deadline to complete a business combination. Trading will be suspended on August 3, 2026, and the company will not appeal.
Key Events · Legal and Risk Events · KVAC
-
Nasdaq Delisting Notice Received
On July 27, 2026, Nasdaq informed KVAC that its securities face delisting due to non-compliance with the SPAC business combination deadline (IM-5101-2), the minimum 1,100,000 publicly held shares requirement, and the minimum 400 total holders requirement.
-
Trading Suspension on August 3
Trading in KVAC's units, ordinary shares, and warrants will be halted at the opening of business on August 3, 2026, with a Form 25-NSE to be filed to formally remove the securities from Nasdaq.
-
No Appeal Planned
The company will not contest the delisting determination, accepting the transition to over-the-counter trading.
-
OTC Trading Expected
After delisting, KVAC's securities are expected to trade on the OTC market, an environment that typically offers lower liquidity and reduced institutional access.
Analysis · KVAC · Real Estate & Construction
A Nasdaq delisting notice landed on Keen Vision Acquisition Corp. on July 27, 2026, triggered by the SPAC's failure to close a business combination within 36 months of its IPO and its inability to meet minimum public float and holder thresholds. With no appeal planned, trading will be suspended on August 3, 2026. For a vehicle already under strain from a terminated merger and heavy trust redemptions, this is a thesis-altering blow. The shift to OTC trading severely curtails liquidity and capital access, making any future deal far more challenging. The company's stated goal of re-listing on Nasdaq upon closing a transaction offers scant near-term reassurance.
At the time of this filing, KVAC was trading at $12.38 on NASDAQ in the Real Estate & Construction sector, with a market capitalization of approximately $73M. The 52-week trading range was $10.67 to $18.72. This filing was assessed with negative market sentiment and an importance score of 10 out of 10.